NCT02672098 2025-05-22
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Loma Linda University
Phase 1 Completed
Clinical Trials
10 trialsNCT06697613 2024-11-20
Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Completed
NCT02567253 2023-11-27
OvIP1
University Hospital, Ghent
Phase 2 Completed
NCT03604653 2022-08-03
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers
Holy Name Medical Center, Inc.
Completed
NCT02475772 2022-07-08
A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis
Ruhr University of Bochum
Phase 1 Completed
NCT02249013 2021-03-18
Short-course HIPEC in Advanced Epithelial Ovarian Cancer
Professor Fernando Figueira Integral Medicine Institute
Phase 2 Completed
NCT04234243 2020-01-29
HIPEC in Ovarian Cancer, Case-Controls Study With 10-years Follow up
Instituto de Seguridad Social del Estado de Mexico y Municipios
Completed
NCT01709487 2016-02-24
Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy
Jules Bordet Institute
Phase 1/2 Completed
NCT00804258 2015-11-06
Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer
City of Hope Medical Center
Completed
NCT01588964 2012-05-01
IPHC
Catholic University of the Sacred Heart
Phase 2 Completed